US Stem Cell Responds to FDA’s Regenerative Medicine Guidelines – Business Wire (press release)
Business Wire (press release) |
US Stem Cell Responds to FDA's Regenerative Medicine Guidelines
Business Wire (press release) It also includes regulatory guidance for off-the-shelf products that, due to their construct, require complex, lengthy and expensive entries to market, since they can involve using modified, third-party stem cells, which can require intense FDA … |
